Today
-0.49%
5 Days
+0.31%
1 Month
-14.06%
6 Months
-8.78%
Year to Date
-21.70%
1 Year
-14.23%
• CVS stock rose due to strong earnings outlook and favorable regulation. • Medicare Advantage payment rates increase benefits CVS's Aetna unit. • Analyst ratings and bullish options trading signal investor confidence.
• Medtronic's share price declined due to negative analyst sentiment. • Cybersecurity incident disclosure contributed to investor concerns and uncertainty. • Stock reached a 52-week low, signaling lack of investor confidence.
• Product safety concerns and regulatory scrutiny impact share price. • Challenges in China and Japan markets affect international growth. • Institutional investors reduced stakes, contributing to price decline.


| Shareholders | Proportion |
|---|---|
| Dodge & Cox | 6.86% |
| Vanguard Capital Management, LLC | 6.35% |
| Capital Research Global Investors | 5.58% |
| BlackRock Institutional Trust Company, N.A. | 5.48% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.87% |
| Investment Advisor/Hedge Fund | 30.52% |
| Research Firm | 2.97% |
| Hedge Fund | 2.93% |
Related Instruments